Text Size

Prediction Tools : Disclaimer

The prediction tools, also known as prognostic nomograms, located on the MSKCC Web site are for general health information only. The prediction tools are not to be used as a substitute for medical advice, diagnosis, or treatment of any health condition or problem.

Users of the prediction tools should not rely on information provided by the prediction tools for their own health problems. Questions should be addressed to your own physician or other healthcare provider.

MSKCC makes no warranties, nor express or implied representations whatsoever, regarding the accuracy, completeness, timeliness, comparative or controversial nature, or usefulness of any information contained or referenced in the prediction tools. MSKCC does not assume any risk whatsoever for your use of the prediction tools or the information contained herein. Health related information changes frequently and therefore information contained in the prediction tools may be outdated, incomplete or incorrect.

Use of the prediction tools does not create an express or implied physician-patient relationship. MSKCC does not endorse or claim validity for the prediction tools found on the MSKCC Web site. The activities and products of MSKCC and its developers and agents (collectively MSKCC) are not endorsed by our past, present, or future employers. MSKCC does not record specific prediction tool user information and does not contact users of the prediction tools.

You are hereby advised to consult with a physician or other professional healthcare provider prior to making any decisions, or undertaking any actions or not undertaking any actions related to any healthcare problem or issue you might have at any time, now or in the future. In using the prediction tools, you agree that neither MSKCC nor any other party is or will be liable or otherwise responsible for any decision made or any action taken or any action not taken due to your use of any information presented in the prediction tools.

I accept all of the above terms by clicking here or by any further use of this service.
I do not accept all of the above terms.

Prediction Tools

We recommend that patients use these prediction tools only in consultation with their physician or other healthcare provider.

Bladder Cancer Nomogram: Post-Surgery

Our bladder nomogram is a prediction tool designed to help physicians and patients decide whether additional treatment is required following bladder removal surgery.

Breast Cancer Nomogram: Post-Surgery

Our breast cancer nomograms can be used to calculate: (1) the likelihood that breast cancer has spread to the sentinel lymph nodes (Sentinel Lymph Nodes Metastasis Nomogram); (2) the likelihood that breast cancer that has spread to the sentinel lymph nodes, has also spread to additional non-sentinel lymph nodes under the arm (Additional Nodal Metastasis Nomogram); and (3) the likelihood that a woman treated with breast-conserving surgery for DCIS (ductal carcinoma in situ) will experience a recurrence in the breast. Each nomogram is designed to individualize the risk estimate for each patient.

Colorectal Cancer Nomogram

Our colorectal cancer nomograms are prediction tools designed to help physicians and patients decide which treatment approaches will result in the greatest benefit.

Clinical Trials: Serious Drug-Related Toxicity in Phase I Clinical Trials Prediction Tool

Our serious drug-related toxicity (SDRT) prediction tool is intended to help physicians estimate the risk of severe drug toxicity for cancer patients who are treated on Phase I trials.

Endometrial Cancer Nomogram

This tool can be used to predict the chance of overall survival following primary therapy for endometrial cancer.

Gastric Carcinoma Nomogram: Post-Surgery

This tool can be used by patients with stomach cancer to calculate the chance of survival after surgery.

Gastrointestinal Stromal Tumor Nomogram

This tool can also be used for patients with gastrointestinal stromal tumors (GIST) to predict the chance they will survive without their cancer returning after receiving surgery alone – i.e. without receiving post-surgery chemotherapy.

Liver Cancer Nomogram: Perioperative Hepatectomy Transfusion

Our liver nomogram predicts the risks involved with receiving a transfusion before, during, or after elective surgical removal of the liver, known as a hepatectomy.

Lung Cancer Screening Decision Tool

Our lung cancer screening decision tool helps clinicians and patients determine the chance that screening will be beneficial based on a patient’s age and smoking history.

Melanoma Nomogram: Sentinel Node Metastasis

Our melanoma nomogram is a tool designed to predict the probability of a positive sentinel lymph node (the first lymph node to which cancer cells are likely to spread from the primary tumor) in patients with melanoma.

Ovarian Cancer Nomogram: Post-Surgery

Our ovarian cancer nomogram is an online tool that can be used to help predict the chance that a patient will not survive five years after primary surgery for epithelial ovarian cancer.

Prostate Cancer Nomogram

Researchers at Memorial Sloan Kettering have pioneered the use of computerized devices called nomograms to help patients and their physicians decide among the major treatment choices for prostate cancer.

Renal Cell Carcinoma Nomogram: Post-Surgery

This nomogram can be used to predict the chance that a patient's kidney cancer will not recur five years after having surgery for renal cell carcinoma.

Sarcoma Nomogram

Our sarcoma nomograms are online prediction tools that can calculate probabilities of survival and disease recurrence based on specific information about the patient and the tumor. These tools can help sarcoma patients and their physicians decide among treatment choices.

Thyroid Cancer Nomogram: Risk of Postoperative Biochemical Hypocalcemia After Total Thyroidectomy

This tool predicts the probability that a patient will have low serum calcium levels after undergoing surgery for the complete removal of the thyroid gland.

Uterine Leiomyosarcoma Nomogram: Overall Survival Probability

This tool can be used to predict the chance of overall survival at five years after a diagnosis of uterine leiomyosarcoma, which is a type of uterine cancer.